The association of lung function and St. George's respiratory questionnaire with exacerbations in COPD: a systematic literature review and regression analysis (Q28070325)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The association of lung function and St. George's respiratory questionnaire with exacerbations in COPD: a systematic literature review and regression analysis	scientific article

Statements

scholarly article

1 reference

3 references

23 July 2019

19 September 2019

22 November 2020

0 references

The association of lung function and St. George's respiratory questionnaire with exacerbations in COPD: a systematic literature review and regression analysis (English)

1 reference

quality of life

1 reference

23 July 2019

chronic obstructive pulmonary disease

3 references

23 July 2019

19 September 2019

22 November 2020

biomedical investigative technique

1 reference

19 September 2019

1 reference

based on heuristic

inferred from title

forced expiratory volume

1 reference

22 November 2020

systematic review

1 reference

based on heuristic

inferred from title

regression analysis

1 reference

based on heuristic

inferred from title

author name string

Amber L. Martin

1

1 reference

Jessica Marvel

2

1 reference

Kyle Fahrbach

3

1 reference

Sarah M. Cadarette

4

1 reference

Teresa K. Wilcox

5

1 reference

James F. Donohue

6

1 reference

language of work or name

1 reference

publication date

16 April 2016

4 references

23 July 2019

19 September 2019

22 November 2020

Respiratory Research

4 references

23 July 2019

19 September 2019

22 November 2020

17

1 reference

1

0 references

40

1 reference

copyright license

Creative Commons Attribution 4.0 International

3 references

Europe PubMed Central

23 July 2019

Europe PubMed Central

19 September 2019

Europe PubMed Central

22 November 2020

copyright status

0 references

on focus list of Wikimedia project

0 references

Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, randomized, double-blind, placebo-controlled study

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833903

20 March 2017

Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833903

20 March 2017

Global burden of COPD: systematic review and meta-analysis

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833903

20 March 2017

Influence of salmeterol/fluticasone via single versus separate inhalers on exacerbations in severe/very severe COPD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833903

29 September 2017

Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833903

29 September 2017

Correlating changes in lung function with patient outcomes in chronic obstructive pulmonary disease: a pooled analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833903

29 September 2017

Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833903

29 September 2017

Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833903

29 September 2017

Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833903

29 September 2017

The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833903

29 September 2017

Defining disease modification in chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833903

29 September 2017

Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833903

29 September 2017

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833903

29 September 2017

Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833903

29 September 2017

The effect of tiotropium on exacerbations and airflow in patients with COPD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833903

29 September 2017

Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833903

29 September 2017

Beclomethasone/formoterol in the management of COPD: a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833903

2 June 2018

COPD in the general population: prevalence, incidence and survival

1 reference

https://api.crossref.org/works/10.1186%2FS12931-016-0356-1

21 January 2018

Response rate or time to progression as predictors of survival in trials of metastatic colorectal cancer or non-small-cell lung cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1186%2FS12931-016-0356-1

21 January 2018

A one-year trial of tiotropium Respimat plus usual therapy in COPD patients

1 reference

https://api.crossref.org/works/10.1186%2FS12931-016-0356-1

21 January 2018

Long-term safety and efficacy of indacaterol, a long-acting β₂-agonist, in subjects with COPD: a randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1186%2FS12931-016-0356-1

21 January 2018

Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations

1 reference

https://api.crossref.org/works/10.1186%2FS12931-016-0356-1

21 January 2018

Short- and long-term efficacy of fluticasone propionate in subjects with early signs and symptoms of chronic obstructive pulmonary disease. Results of the DIMCA study

1 reference

https://api.crossref.org/works/10.1186%2FS12931-016-0356-1

21 January 2018

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

1 reference

https://api.crossref.org/works/10.1186%2FS12931-016-0356-1

21 January 2018

Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials.

1 reference

https://api.crossref.org/works/10.1186%2FS12931-016-0356-1

21 January 2018

Effect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomes

1 reference

https://api.crossref.org/works/10.1186%2FS12931-016-0356-1

21 January 2018

Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study

1 reference

https://api.crossref.org/works/10.1186%2FS12931-016-0356-1

21 January 2018

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1186%2FS12931-016-0356-1

21 January 2018

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1186%2FS12931-016-0356-1

21 January 2018

Extrafine beclomethasone/formoterol in severe COPD patients with history of exacerbations.

1 reference

https://api.crossref.org/works/10.1186%2FS12931-016-0356-1

21 January 2018

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide

1 reference

https://api.crossref.org/works/10.1186%2FS12931-016-0356-1

21 January 2018

Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study

1 reference

https://api.crossref.org/works/10.1186%2FS12931-016-0356-1

21 January 2018

Evaluation of the efficacy and safety of tiotropium bromide (5 µg) inhaled via Respimat in Chinese patients with chronic obstructive pulmonary disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833903

27 November 2018

Identifiers

10.1186/S12931-016-0356-1

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Dimensions Publication ID

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/s12931-016-0356-1

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28070325&oldid=2177443370"